David L. Brinkley, Head of Business Development at THERAVANCE INC (THRX), sold 16,129 shares at $34.77 ($561K) on 2013-05-03, disclosed to the SEC on 2013-05-07.
Scheduled sale ($561k) by Head of Business Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| THRX | SELL | 2013-05-02 | $577K | — | Filing → |
| THRX | SELL | 2012-08-28 | $96K | — | Filing → |
| THRX | SELL | 2012-08-07 | $3.5M | — | Filing → |